retaine MGD

Light Mineral Oil (0.5%)
Mineral Oil (0.5%)

Emollient

For use as a protectant against further irritation or to relieve dryness of the eye.

For use in the eyes only.

• if this product changes color.

• do not touch tip of container to any surface to avoid contamination.
• do not reuse once opened.

• you feel eye pain or changes in vision, continued redness or irritation of the eye.
• the condition worsens or persists for more than 72 hours.

If swallowed, get medical help or contact a Poison Control Center immediately.

• Shake well before using.
• Instill 1 or 2 drops in the affected eye(s) as needed and discard container.

• Use only if tamper seals on top and bottom flaps are intact.
• Drops appear as a milky white emulsion.
• Store between 15 ^o-30 ^oC (59 ^o-86 ^oF).

Cetrimonium Bromide, glycerin, poloxamer 188, tris hydrochloride, tromethamine, tyloxapol, water for injection.

Call (800) 233-5469 M-F 8:30AM-5:30PM CST
or visit www.ocusoft.com

NDC 54799-917-30

OCuSOFT ^®

MGD™
ADVANCED™

Lubricant Eye Drops

Non-Preserved^{*
Relieves Irritation
Long-Lasting Comfort}

Superior Dry Eye Relief
Without A Prescription

30 Sterile
Single-Dose Vials
0.01 fl oz (0.4 mL) each

Retaine^® MGD™ Advanced™ is
a non-preserved^* ophthalmic
emulsion that delivers complete
Dry Eye relief utilizing a
proprietary oil in water emulsion
technology (microemulsification)
with electrostatic attraction to
restore the three layers of the
tear film without blurring.

Replenishes LIPID LAYER and
reduces tear evaporation

Adds moisture to AQUEOUS
LAYER

Lubricates and protects
MUCIN LAYER

^*Cetrimonium bromide is a cationic
stabilizer and is not added as a
preservative.

Positively Charged
Retaine^® MGD™
Droplets

Negatively Charged
Ocular Surface

Use only if twist top of
single-dose vial is intact.

OCuSOFT^®
Manufactured for OCuSOFT LLC.
Rosenberg, TX 77471 USA
© 2025 OCuSOFT Inc.
www.ocusoft.com
Patents: www.ocusoft.com/patents

All registered trademarks are property of
OCuSOFT Inc.

[Image in the official label — see DailyMed source]